Cargando…

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report

Atrioventricular (AV) nodal blockers have a wide variety of medical uses, including the management of hypertension and cardiac arrhythmias. Like any other drug, they can carry side effects and toxicity. We present a case of a patient with a constellation of findings consistent with bradycardia, rena...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez, Adolfo, Shah, Niket, Kim, Andrew, Watat, Kevin, Banga, Sandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907465/ https://www.ncbi.nlm.nih.gov/pubmed/36779105 http://dx.doi.org/10.7759/cureus.33544

Ejemplares similares

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
por: Afzal, Muhammad A, et al.
Publicado: (2023)

A Combination of Beta-Blockade and Calcium Channel Blockade Leading to Bradycardia, Renal Failure, Atrioventricular Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Case Report
por: Patel, Kunj, et al.
Publicado: (2023)

“Feeling the Blues”: A Case of Calcium Channel Blocker Overdose Managed With Methylene Blue
por: Pellegrini, James R, et al.
Publicado: (2021)

The vicious cycle of BRASH syndrome: A case report
por: Saini, Twinkle, et al.
Publicado: (2023)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity
por: Woodward, Christina, et al.
Publicado: (2014)

A Case of BRASH Syndrome in an Elderly Female With Acute Urinary Retention
por: Mahmood, Rabia, et al.
Publicado: (2023)

BRASH Syndrome Presenting With Idioventricular Escape Rhythm in a Patient With Trifascicular Block
por: Aiwuyo, Henry O, et al.
Publicado: (2022)

Symptomatic Junctional Bradycardia Due to Untreated Hypothyroidism After Beta-Blocker Discontinuation: A Case Report
por: Rahimi, Osman, et al.
Publicado: (2023)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

The Role of Verapamil Toxicity in the Vicious Cycle of Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Case Report
por: Kazim, Yasmin H, et al.
Publicado: (2022)

BRASH Syndrome Leading to Cardiac Arrest and Diffuse Anoxic Brain Injury: An Underdiagnosed Entity
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2021)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Calcium Channel Blocker Toxicity: A Practical Approach
por: Alshaya, Omar A, et al.
Publicado: (2022)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
por: Ardissino, Maddalena, et al.
Publicado: (2022)

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
por: Chakraborty, Rabindra Nath, et al.
Publicado: (2021)

A Case Report on BRASH (Bradycardia, Renal Failure, Atrioventricular Blockade, Shock, and Hyperkalaemia) Syndrome: A Challenging Diagnosis
por: Roy, Pooja, et al.
Publicado: (2022)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
por: BAYCAN, Omer Faruk, et al.
Publicado: (2023)

Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Rising Entity of Severe Bradycardia
por: Ng, Choong Tatt, et al.
Publicado: (2023)

Transthyretin Cardiac Amyloidosis Presenting as Bradycardia, Renal Failure, Atrioventricular-Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Case Report
por: Khatun, Nazima, et al.
Publicado: (2023)

Cardiovascular Collapse Secondary to Beta-Blocker Administration in a Setting of Coexisting Thyroid Storm and Atrial Fibrillation: A Case Report
por: Bokhari, Syed Faqeer Hussain, et al.
Publicado: (2022)

The Use of High-dose Insulin Infusion and Lipid Emulsion Therapy in Concurrent Beta-blocker and Calcium Channel Blocker Overdose
por: Lashari, Bilal H, et al.
Publicado: (2018)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension
por: Yamaguchi, Satoshi, et al.
Publicado: (2023)

Bradycardia, Renal Failure, Atrioventricular-nodal Blocker, Shock, and Hyperkalemia Syndrome Diagnosis and Literature Review
por: Sattar, Yasar, et al.
Publicado: (2020)

The evaluation of beta blocker and calcium antagonist drugs
Publicado: (1982)

BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE COMPLICATED BY COVID-19 PNEUMONIA AND RENAL FAILURE IN A PATIENT WITH SEVERE OBESITY
por: GARCIA, ALEJANDRO, et al.
Publicado: (2022)

Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
por: Lovell, Mark A., et al.
Publicado: (2015)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eftcnr8nfg207t8pevon6it66g